Russia’s announcement of developing a COVID-19 vaccine has generated mixed responses world over with a section of medical experts doubting the effectiveness of the vaccine. Amidst heavy discussions over its claims, Russia has now said its vaccine is currently recommended for those between 18 to 60 years of age.
Vladimir Bondarev, the head of the Russian Health Ministry’s Scientific Centre for Expert Evaluation of Medicinal Products, specified that the clinical trials were carried out on the volunteers aged 18 to 60 years.
“In Russia, it is customary to certify vaccines for children from birth to 18 years old; adults from 18 to 60 years old; and elders over 60 years of age. Clinical studies have now been carried out on a group of volunteers aged from 18 to 60 years old. Thus, this vaccine is now indicated for use in people from 18 to 60 years old,” said Bondarev.
However, Bondarev also informed that the trials for other age-groups are expected to be conducted soon.
Russian President Vladimir Putin had announced on Tuesday (August 11) that Moscow has registered the world’s first COVID-19 vaccine and claimed that it is “quite effective and forms a lasting immunity”.